Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1826]
News [2739]
Articles [202]
Editorials [1]
Conferences [136]
elearning [13]
Peri-operative lapatinib has profound antiproliferative effect in early breast...
Prof Nigel Bundred - University of Manchester, Manchester, United Kingdom
Peri-operative lapatinib has profound antiproliferative effect in early breast cancer ( Prof Nigel Bundred - University of Manchester, Manchester, United Kingdom )
14 Dec 2015
Guidelines and management of advanced breast cancer in limited resource settings
Prof Nagi S. El Saghir - American University of Beirut, Beirut, Lebanon
Guidelines and management of advanced breast cancer in limited resource settings ( Prof Nagi S. El Saghir - American University of Beirut, Beirut, Lebanon )
14 Dec 2015
New developments and technologies in hereditary cancer
Dr Johnathan Lancaster - Chief Medical Officer of Myriad Genetics, Salt Lake...
New developments and technologies in hereditary cancer ( Dr Johnathan Lancaster - Chief Medical Officer of Myriad Genetics, Salt Lake City, USA )
14 Dec 2015
Results of the CREATE-X trial
Dr Masakazu Toi - Kyoto University, Kyoto, Japan
Results of the CREATE-X trial ( Dr Masakazu Toi - Kyoto University, Kyoto, Japan )
14 Dec 2015
Improved survival outcomes in women with HER2-negative breast cancer after...
Dr Masakazu Toi - Kyoto university, Kyoto, Japan
Improved survival outcomes in women with HER2-negative breast cancer after neoadjuvant chemotherapy ( Dr Masakazu Toi - Kyoto university, Kyoto, Japan )
10 Dec 2015
Adding carboplatin to presurgery chemotherapy improved disease-free survival...
Prof Gunter von Minckwitz - German Breast Group, Neu-Isenburg, Germany
Adding carboplatin to presurgery chemotherapy improved disease-free survival for patients with triple-negative breast cancer ( Prof Gunter von Minckwitz - German Breast Group, Neu-Isenburg, Germany )
10 Dec 2015
Women with luminal A breast cancer subtype do not seem to benefit from adjuvant...
Dr Torsten Nielsen - University of British Columbia, Vancouver, Canada
Women with luminal A breast cancer subtype do not seem to benefit from adjuvant chemotherapy ( Dr Torsten Nielsen - University of British Columbia, Vancouver, Canada )
9 Dec 2015
Pathologic complete response to presurgery chemo improves survival for triple...
Dr William Sikov - Women & Infants Hospital of Rhode Island, Providence, USA
Pathologic complete response to presurgery chemo improves survival for triple-negative breast cancer ( Dr William Sikov - Women & Infants Hospital of Rhode Island, Providence, USA )
9 Dec 2015
Radiotherapy access in low and middle income countries
Dr Mary Gospodarowicz -Director, Princess Margaret Cancer Foundation
Radiotherapy access in low and middle income countries ( Dr Mary Gospodarowicz -Director, Princess Margaret Cancer Foundation )
8 Dec 2015
The work of the Global Academic Program in Africa
Dr Oliver Bogler - MD Anderson Cancer centre, Houston, USA
The work of the Global Academic Program in Africa ( Dr Oliver Bogler - MD Anderson Cancer centre, Houston, USA )
8 Dec 2015
ASH 2015: Latest in CLL
Prof John Gribben, Prof Stephan Stilgenbauer, Dr Alessandra Tedeschi, Dr...
ASH 2015: Latest in CLL ( Prof John Gribben, Prof Stephan Stilgenbauer, Dr Alessandra Tedeschi, Dr Patrick Thornton )
7 Dec 2015
The impact of microbiota on the immune response
Dr Giorgio Trinchieri - Center for Cancer Research, Bethesda, USA
The impact of microbiota on the immune response ( Dr Giorgio Trinchieri - Center for Cancer Research, Bethesda, USA )
7 Dec 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation